The trials with talc and mesothelioma issues are getting tougher, with more and better experts for the defense.  The result of a 3...

Today’s post is a shameless and sincere push for you, your companies and your clients to invest at least 45 minutes to learn about one of...

Maybe, maybe, maybe a glimmer of moving down a path towards proactive cancer avoidance treatment in women with inherited BRCA-1...

Gordon & Reese put out a May 31, 2016 blog post indicating asbestos defendants in non-smoker  lung cancer cases may want to argue tumors...

The C8 litigation is continuing into possible trial #3, and outcome #4.  The results to date – and the trials ahead – are summarized in a...

Immunotherapy for cancer is the new thing, and it shows great promise, but also difficulties. For a good overview explanation, see this...

A brief review of the BAP1 “meso gene” discovery story is provided  – with links to key articles – in the April 1, 2016  issue of the...

Various articles (e.g. here) keep repeating the myth that “the BAP1 defense” was “defeated” in a “verdict” in  the Perez case in...

Now in the books is the first mesothelioma trial to squarely put at issue the legal consequences when the mesothelioma victim  inherited...

A few years ago, “toxic tort” trials in St. Louis were not so common. Today, there are ample numbers of asbestos cases, with cases going...

“Cancer” is a beast that kills 560,000 Americans per year, and millions more around the globe. “Cancer” akes many forms, most of which...

Trial has finally arrived for the long-pending and much litigated Donovan class action against big tobacco in federal court in...

Image from Illumina’s press conference announcing a bold new plan to change how the world deals with cancer. Did you feel the earth move...

Plaintiff firms involved in asbestos litigation like to have the internet pulsing with references to asbestos and litigation. To that...

Cartoon courtesy of Campaign for Tobacco Free Kids. You knew this well-targeted attack was going to be launched by someone. Kudos to the...

Researchers depend in part on “lines” of mice bred and raised to be the same, and assumed to be the same.  The assumptions are being...

It’s hard to believe, but the pace of molecular science continues to accelerate. And it’s increasingly focused on disease causation...

Some people assume change in law is always slow. Is that really true? Not always. Consider all of the ongoing change regarding the...

Daunting data on viruses and cancer is set out in a new, open access article in Cancer Epidemiology. The article is part of the European...

One of the struggles in mass tort litigation arises from the economic conflicts of interest between current and future claimants. The...